Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Respiratory, thoracic and mediastinal disorders – page 109

  • 1 304 clinical trials
  • 448 recruiting
  • 382 conditions
  • 29 countries

Conditions in this area

382 conditions with trials, the busiest first

Non-small cell lung cancer335Asthma90Non-small cell lung cancer metastatic84Chronic obstructive pulmonary disease62Non-small cell lung cancer stage IV58Pulmonary arterial hypertension41COVID-1939Non-small cell lung cancer stage III38Small cell lung cancer35Idiopathic pulmonary fibrosis34Pneumonia33Interstitial lung disease31Non-small cell lung cancer stage IIIB31Small cell lung cancer extensive stage31Influenza29Lung neoplasm malignant29Pulmonary hypertension25Conjunctivitis allergic24Cystic fibrosis24Respiratory syncytial virus infection22Chronic rhinosinusitis with nasal polyps21Rhinitis allergic20Post-acute COVID-19 syndrome19Ovarian cancer18+358

Clinical trials in Respiratory, thoracic and mediastinal disorders

1 304 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

1 304 clinical trials

Non-small cell lung cancer

Not recruiting

Study on the Safety and Effectiveness of Volrustomig with a Drug Combination for Patients with Solid Tumors

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Non-small cell lung cancer

Not recruiting

Study on Additional Chemotherapy with Osimertinib, Carboplatin, and Cisplatin for Patients with Advanced Non-Small Cell Lung Cancer and EGFR Mutation

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Goethe University Frankfurt

Renal cancer+4

Not recruiting

Study on the Effectiveness of Atezolizumab with Radiotherapy for Patients with Metastatic Colorectal, Lung, Renal, and Sarcoma Cancers

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Institut Gustave Roussy

Asthma

Not recruiting

Study on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Alveolar proteinosis

Not recruiting

Study of Inhaled Molgramostim for Adults with Autoimmune Pulmonary Alveolar Proteinosis

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Molgramostim
  • Sponsor:Savara ApS

Non-small cell lung cancer

Not recruiting

Study on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Non-small cell lung cancer

Not recruiting

Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Clinipace Global Limited

Non-small cell lung cancer+1

Not recruiting

Study of Tiragolumab and Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Substances studied in this area

The therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.

Carboplatin174 clinical trialsPembrolizumab148 clinical trialsCisplatin130 clinical trialsPemetrexed111 clinical trialsPaclitaxel83 clinical trialsDurvalumab73 clinical trialsSodium Chloride53 clinical trialsAtezolizumab52 clinical trialsNivolumab49 clinical trials
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.